Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-050409
Filing Date
2025-04-03
Accepted
2025-04-03 16:16:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3718
  Complete submission text file 0000950170-25-050409.txt   5348
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Subject) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38470 | Film No.: 25809689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SOLID BIOSCIENCES, LLC 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address
Sullivan Lynne Marie (Reporting) CIK: 0001727640 (see all company filings)

Type: 144